Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective | Contract Pharma

What are you searching for?

Sign in
Case Studies

How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective

Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.

Released By Syngene International Ltd.

Transformative innovation in the pharmaceutical industry has resulted in an explosion in the types of novel modalities and therapies.
 
The world of drug discovery and development is rife with new approaches within immunotherapy, personalized vaccines, microbiome therapies, and CRISPR-based therapies to provide novel treatments and cures for a wide range of diseases. Even though progress is being made in these areas, more than 90 % of the drugs currently available on the worldwide therapeutics market are small molecules based.

DOWNLOAD NOW TO READ MORE >>>>

Download Case Studies Now

Download Case Studies Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters